✦ LIBER ✦

Intravenous Methotrexate as Initial Treatment for Primary Central Nervous System Lymphoma: Response to Therapy and Quality of Life of Patients

✍ Scribed by Nandita Guha-Thakurta; Denise Damek; Craig Pollack; Fred H. Hochberg

Book ID: 110233138
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 62 KB
Volume: 43
Category: Article
ISSN: 0167-594X
DOI: 10.1023/a:1006210703827

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose methotrexate with R-CHOP thera

High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma

✍ Yasufumi Masaki; Miyuki Miki; Yue Sun; Takuji Nakamura; Haruka Iwao; Akio Nakaji 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 295 KB

Primary central nervous system lymphoma:

Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy

✍ Meltem Ekenel; Fabio M. Iwamoto; Leah S. Ben-Porat; Katherine S. Panageas; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Reply to intravenous methotrexate as cen

Reply to intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Ephraim P. Hochberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

I read with great interest the article by Cooperberg and coworkers 1 studying survival rates in differently treated men with early prostate cancer. In this study, patients who underwent radical prostatectomy had a substantially decreased disease-specific mortality, particularly in the higher-risk gr